• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

创新技术——经导管主动脉瓣植入术:成本与报销问题。

Innovative technology-transcatheter aortic valve implantation: cost and reimbursement issues.

机构信息

Department of Cardiothoracic Surgery, University of Oslo, Oslo, Norway.

出版信息

Scand Cardiovasc J. 2012 Dec;46(6):345-52. doi: 10.3109/14017431.2012.724177. Epub 2012 Oct 18.

DOI:10.3109/14017431.2012.724177
PMID:22917262
Abstract

OBJECTIVE

Transcatheter aortic valve implantation (TAVI) offers a new treatment option for patients with severe symptomatic aortic valve stenosis, classified as "inoperable". The purpose of the study was to reveal the association between ascertained hospital costs with the actual patient Diagnosis-Related Group (DRG).

METHOD

We examined 50 consecutive patients who underwent either transapical TAVI, (TAVI-TA) or transfemoral TAVI (TAVI-TF) with the Edwards SAPIEN valve and CoreValve(®) between September 2009 and August 2011.

RESULTS

Fourty-nine patients had successful valve deployment. Seven patients died within 30 days of the operation. The mean length of hospital stay for TAVI-TA was 199 hours (range 77-362), and the mean costs for TAVI-TA were 55,690 US$. For TAVI-TF the mean length of hospital stay was 170 hours (range 49-276) and the mean costs were 52,087 US$.

CONCLUSION

There was no significant difference between TAVI-TA and TAVI-TF patient characteristics. There was a significant discrepancy between actual hospital costs and the current Norwegian DRG reimbursement for the TAVI procedure. This discrepancy can be partly explained by excessive costs related to the introduction of a new program with new technology. Costly innovations should be considered in price-setting of reimbursement for novel technology.

摘要

目的

经导管主动脉瓣植入术(TAVI)为严重症状性主动脉瓣狭窄患者(被归类为“不可手术”的患者)提供了一种新的治疗选择。本研究旨在揭示已确定的医院费用与实际患者诊断相关组(DRG)之间的关联。

方法

我们检查了 2009 年 9 月至 2011 年 8 月期间接受经心尖 TAVI(TAVI-TA)或经股动脉 TAVI(TAVI-TF)的 50 例连续患者,这些患者均使用爱德华兹 SAPIEN 瓣膜和 CoreValve(®)。

结果

49 例患者的瓣膜植入成功。7 例患者在手术后 30 天内死亡。TAVI-TA 的平均住院时间为 199 小时(范围为 77-362),TAVI-TA 的平均费用为 55690 美元。对于 TAVI-TF,平均住院时间为 170 小时(范围为 49-276),平均费用为 52087 美元。

结论

TAVI-TA 和 TAVI-TF 患者特征之间没有显著差异。实际医院费用与当前挪威 TAVI 程序的 DRG 报销之间存在显著差异。这种差异部分可以解释为与新技术引入相关的过高成本。对于新技术的定价,应考虑昂贵的创新。

相似文献

1
Innovative technology-transcatheter aortic valve implantation: cost and reimbursement issues.创新技术——经导管主动脉瓣植入术:成本与报销问题。
Scand Cardiovasc J. 2012 Dec;46(6):345-52. doi: 10.3109/14017431.2012.724177. Epub 2012 Oct 18.
2
[The cost of innovation in treating aortic stenosis: transcatheter aortic valve implantation].
G Ital Cardiol (Rome). 2012 Jan;13(1):50-8. doi: 10.1714/1015.11056.
3
Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis.经导管主动脉瓣置换术在导管室(极简方法)与杂交手术室(标准方法)中的比较:结果和成本分析。
JACC Cardiovasc Interv. 2014 Aug;7(8):898-904. doi: 10.1016/j.jcin.2014.04.005. Epub 2014 Jul 30.
4
Cost of transcatheter aortic valve implantation and factors associated with higher hospital stay cost in patients of the FRANCE (FRench Aortic National CoreValve and Edwards) registry.法国(FRench Aortic National CoreValve 和 Edwards)注册研究中心的经导管主动脉瓣植入术的成本及与住院费用较高相关的因素。
Arch Cardiovasc Dis. 2013 Apr;106(4):209-19. doi: 10.1016/j.acvd.2013.01.006. Epub 2013 Apr 24.
5
Transcatheter aortic valve implantation for high risk patients with severe aortic stenosis using the Edwards Sapien balloon-expandable bioprosthesis: a single centre study with immediate and medium-term outcomes.经导管主动脉瓣植入术治疗高危重度主动脉瓣狭窄患者使用 Edwards Sapien 球囊扩张生物瓣:单中心即时和中期结果研究。
Catheter Cardiovasc Interv. 2010 Mar 1;75(4):475-85. doi: 10.1002/ccd.22291.
6
Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry.CoreValve或爱德华兹经导管主动脉瓣植入术后的手术、30天及1年结局:比利时国家注册研究结果
Interact Cardiovasc Thorac Surg. 2011 May;12(5):762-7. doi: 10.1510/icvts.2010.253773. Epub 2011 Feb 24.
7
The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk.经导管主动脉瓣植入术与外科主动脉瓣置换术治疗高危手术风险重度主动脉瓣狭窄患者的成本效益比较。
Heart. 2013 Jul;99(13):914-20. doi: 10.1136/heartjnl-2013-303722. Epub 2013 May 21.
8
Costs of periprocedural complications in patients treated with transcatheter aortic valve replacement: results from the Placement of Aortic Transcatheter Valve trial.经导管主动脉瓣置换术治疗患者围手术期并发症的成本:来自 Placement of Aortic Transcatheter Valve 试验的结果。
Circ Cardiovasc Interv. 2014 Dec;7(6):829-36. doi: 10.1161/CIRCINTERVENTIONS.114.001395. Epub 2014 Oct 21.
9
Is EuroSCORE II better than EuroSCORE in predicting mortality after transcatheter aortic valve implantation?EuroSCORE II 比 EuroSCORE 在预测经导管主动脉瓣植入术后死亡率方面更优吗?
Catheter Cardiovasc Interv. 2013 May;81(6):1053-60. doi: 10.1002/ccd.24702. Epub 2013 Feb 12.
10
Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience.单中心经导管主动脉瓣植入术(Edwards-SAPIEN 和 CoreValve 两种装置)的结果:米兰经验。
JACC Cardiovasc Interv. 2010 Nov;3(11):1110-21. doi: 10.1016/j.jcin.2010.09.012.

引用本文的文献

1
To pay or not to pay for artificial intelligence applications in radiology.放射学中人工智能应用是否付费的问题。
NPJ Digit Med. 2023 Jun 23;6(1):117. doi: 10.1038/s41746-023-00861-4.
2
In-hospital cost comparison between percutaneous pulmonary valve implantation and surgery.经皮肺动脉瓣植入术与外科手术的院内成本比较
Eur J Cardiothorac Surg. 2017 Apr 1;51(4):747-753. doi: 10.1093/ejcts/ezw378.
3
Barriers to medical device innovation.医疗设备创新的障碍。
Med Devices (Auckl). 2014 Jun 13;7:205-9. doi: 10.2147/MDER.S43369. eCollection 2014.